These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7735218)

  • 1. A convenient screening test for hypoxic cell radiosensitizers/cytotoxins.
    Hori H; Yokoyama H; Nagasawa H; Murayama C; Mori T; Yonei S; Satoh T; Inayama S
    Biol Pharm Bull; 1994 Dec; 17(12):1676-8. PubMed ID: 7735218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
    Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
    J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
    Weinmann M; Welz S; Bamberg M
    Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers.
    Papadopoulou MV; Rosenzweig HS; Bloomer WD
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1523-5. PubMed ID: 15006395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline].
    Skov KA; Adomat H; Doedee M; Farrell N
    Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of hypoxia-targeting drugs as new cancer chemotherapeutics.
    Nagasawa H; Uto Y; Kirk KL; Hori H
    Biol Pharm Bull; 2006 Dec; 29(12):2335-42. PubMed ID: 17142959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicinal electronomics bricolage design of hypoxia-targeting antineoplastic drugs and invention of boron tracedrugs as innovative future-architectural drugs.
    Hori H; Uto Y; Nakata E
    Anticancer Res; 2010 Sep; 30(9):3233-42. PubMed ID: 20944092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the repair and damage of DNA induced by parent and reduced RSU-1069, a 2-nitroimidazole-aziridine.
    O'Neill P; Cunniffe SM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):963-6. PubMed ID: 2649467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical radiosensitizers for use in radiotherapy.
    Wardman P
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation.
    Cowan DS; Kanagasabapathy VM; McClelland RA; Rauth AM
    Int J Radiat Oncol Biol Phys; 1992; 22(3):541-4. PubMed ID: 1735693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitizing hypoxic cells with new 3-nitro-1,2,4-triazole derivatives in vitro and in vivo.
    Nagao Y; Sano S; Ochiai M; Fuji K; Nishimoto S; Kagiya T; Murayama C; Mori T; Shibamoto Y; Sasai K
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1951-3. PubMed ID: 2805177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins.
    Threadgill MD; Webb P; O'Neill P; Naylor MA; Stephens MA; Stratford IJ; Cole S; Adams GE; Fielden EM
    J Med Chem; 1991 Jul; 34(7):2112-20. PubMed ID: 2066984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers.
    Jin CZ; Nagasawa H; Shimamura M; Uto Y; Inayama S; Takeuchi Y; Kirk KL; Hori H
    Bioorg Med Chem; 2004 Sep; 12(18):4917-27. PubMed ID: 15336271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Alkylsulfonyloxy-3-hydroxy-1,4-naphthoquinones: a novel class of radio- and chemosensitizers of V79 cells.
    Hatzigrigoriou E; Papadopoulou MV; Shields D; Bloomer WD
    Oncol Res; 1993; 5(1):29-36. PubMed ID: 8369573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activated cytotoxins.
    Jenkins TC; Naylor MA; O'Neill P; Threadgill MD; Cole S; Stratford IJ; Adams GE; Fielden EM; Suto MJ; Stier MA
    J Med Chem; 1990 Sep; 33(9):2603-10. PubMed ID: 2391699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failla Memorial Lecture. Redox, radiation, and reductive bioactivation.
    Adams GE
    Radiat Res; 1992 Nov; 132(2):129-39. PubMed ID: 1438693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.
    Hay MP; Lee HH; Wilson WR; Roberts PB; Denny WA
    J Med Chem; 1995 May; 38(11):1928-41. PubMed ID: 7783125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells].
    Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI
    Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic advantage of hypoxic cells in tumors: a theoretical study.
    Brown JM; Koong A
    J Natl Cancer Inst; 1991 Feb; 83(3):178-85. PubMed ID: 1988703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Arylidene-4-cyclopentene-1,3-diones designed as non-nitro radiosensitizers and hypoxic cytotoxins.
    Hori H; Maezawa H; Iitaka Y; Ohsaka T; Shibata T; Mori T; Inayama S
    Jpn J Cancer Res; 1987 Oct; 78(10):1128-33. PubMed ID: 3119546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.